TITLE

Profile of retinal vasculitis in a tertiary eye care center in Eastern India

AUTHOR(S)
Saurabh, Kumar; Das, Radha R.; Biswas, Jyotirmay; Kumar, Amitabh
PUB. DATE
July 2011
SOURCE
Indian Journal of Ophthalmology;Jul2011, Vol. 59 Issue 4, p297
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
To provide a fact file on the etiology, clinical presentations and management of retinal vasculitis in Eastern India. Materials and Methods: Retrospective, record based analysis of retinal vasculitis cases in a tertiary care center in Eastern India from January 2007 to December 2009. Results: One hundred and thirteen eyes of 70 patients of retinal vasculitis were included in this study. Sixty (85.7%) patients were male (mean age 33+11.1 years) and 10 (14.3%) were female (mean age 32.4+13.6 years). Vasculitis was bilateral in 43 (61.4%) and unilateral in 27 (38.6%) patients. Commonest symptoms were dimness of vision (73; 64.6%) and floaters (36; 31.9%). Vascular sheathing (82; 72.6%) and vitritis (51; 45.1%) were commonest signs. Mantoux test was positive in 21 (30%) patients but tuberculosis was confirmed in only four (5.71%) patients. Raised serum angiotensin-converting enzyme level and positive antinuclear antibody level were reported in four (5.71%) patients each. Human leukocyte antigen B5 (HLA B5) marker was present in one (1.4%) patient. However, none of the total 70 patients were found to have a conclusively proven systemic disease attributable as the cause of retinal vasculitis. Oral corticosteroid (60; 85.7%) was the mainstay of treatment. Forty-eight (42.5%) eyes maintained their initial visual acuity and 43 (38%) gained one or more line at mean follow-up of 16.6+6.3 months. Conclusion: Retinal vasculitis cases had similar clinical presentations and common treatment plan. There was no systemic disease association with vasculitis warranting a careful approach in prescribing investigations.
ACCESSION #
61834905

 

Related Articles

  • To x-ray or not to x-ray? Screening asymptomatic children for pulmonary TB: a retrospective audit. Gwee, Amanda; Pantazidou, Anastasia; Ritz, Nicole; Tebruegge, Marc; Connell, Tom G.; Cain, Tim; Curtis, Nigel // Archives of Disease in Childhood;Jun2013, Vol. 98 Issue 6, p401 

    Objective Recent studies found that a chest x-ray (CXR) has limited value in the assessment of asymptomatic adults with tuberculosis (TB) infection. We aimed to determine in asymptomatic children with a positive tuberculin skin test and/or interferon-? release assay (TST/IGRA) whether a CXR...

  • Assessment of tine tuberculin test. Sinclair, D.J.M.; Johnston, R.N. // British Medical Journal;5/19/1979, Vol. 1 Issue 6174, p1325 

    Examines the tine tuberculin test on patients with pulmonary tuberculosis. Comparison between the tuberculin sensitivity using the tine disc and Mantoux tests; Application of the test on the volar aspect of one arm; Significant difference between the readings of the techniques.

  • Sequestration of T Lymphocytes to Body Fluids in Tuberculosis: Reversal of Anergy following Chemotherapy. Dieli, Francesco; Friscia, Giuseppe; Di Sano, Caterina; Ivanyi, Juraj; Singh, Mahavir; Spallek, Ralph; Sireci, Guido; Titone, Lucina; Salerno, Alfredo // Journal of Infectious Diseases;7/1/99, Vol. 180 Issue 1, p225 

    Studies the specificity of CD4 T lymphocytes in six patients affected by tuberculosis who had negative tuberculin purified protein derivative (PPD) skin tests at diagnosis. Patients' response to PPD after chemotherapy; Compartmentalization of CD4 T cells; Occurrence of anergy in patients...

  • Treatment of Latent Tuberculosis Infection: Renewed Opportunity for Tuberculosis Control. Cohn, David L. // Clinical Infectious Diseases;7/1/2000, Vol. 31 Issue 1, p120 

    Presents recommendations for targeted tuberculin testing and treatment of latent tuberculosis infection (LTBI). Significance of the changes in nomenclature from screening to targeted tuberculin testing and from preventive therapy to treatment of LTBI; Suggested drug regimens for LTBI;...

  • Relationship Between Tuberculin Skin Test (TST) Size and Interferon Gamma Release Assay (IGRA) Result: When Should Clinicians Obtain IGRAs in Children With Positive TSTs? Cruz, Andrea T.; Starke, Jeffrey R. // Clinical Pediatrics;Oct2014, Vol. 53 Issue 12, p1196 

    The article discusses a study on the association between Interferon Gamma Release Assays (IGRAs) and Tuberculin Skin Test (TST) among children referred by pediatricians and clinics who did not participate in health department contact investigations. Topics discussed include an evaluation if IGRA...

  • Risk for Tuberculosis Disease Among Contacts with Prior Positive Tuberculin Skin Test: A retrospective Cohort Study, New York City. Gounder, Prabhu; Harris, Tiffany; Anger, Holly; Trieu, Lisa; Meissner, Jeanne; Cadwell, Betsy; Shashkina, Elena; Ahuja, Shama // JGIM: Journal of General Internal Medicine;Jun2015, Vol. 30 Issue 6, p742 

    Background: Patients with prior positive tuberculin skin test (TST) results may benefit from prophylaxis after repeat exposure to infectious tuberculosis (TB). Objective: To evaluate factors associated with active TB disease among persons with prior positive TST results named as contacts of...

  • Case 34-1994: Laryngeal Tuberculosis. Rossi, Renée M. // New England Journal of Medicine;3/2/95, Vol. 332 Issue 9, p610 

    A response by Renee M. Rossi to letters to the editor about her article on a patient with tuberculosis and tuberculin testing is presented.

  • Interferon-γ and Interleukin-17 production from PPD-stimulated PBMCss of patients with pulmonary tuberculosis. Nunnari, Giuseppe; Pinzone, Marilia R.; Vancheri, Carlo; Palermo, Filippo; Cacopardo, Bruno // Clinical & Investigative Medicine;2013, Vol. 36 Issue 2, pE64 

    Purpose: The purpose of this study was to evaluate Interferon (IFN)-γ and Interleukin(IL)-17 profiles in patients with different clinical presentations of pulmonary tuberculosis (TB) and to compare them with those of tuberculin-negative and tuberculinreactive healthy controls Methods:...

  • Three Months, 27 Supervised Doses for Latent TB. Deresinski, Stan // Infectious Disease Alert;Jul2011, Vol. 30 Issue 10, p112 

    The number of individuals with active tuberculosis in the United States reached an all-time low of 11,181 cases in 2010. At the same time, it is estimated that approximately 11 million people, or 4% of the population, is latently infected and at risk of developing active disease due to...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics